Business Description
Adagene is a China-based biotechnology company focused on developing antibody-based treatments for cancer. Founded in 2011 and headquartered in Suzhou, the company has built a broad pipeline of drug candidates at various stages of clinical testing, targeting both solid tumors and blood cancers. Its portfolio includes several antibody therapies designed to improve how the immune system attacks cancer cells, with some already in mid-stage clinical trials and others still in early research.
